Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $464.08 | 12 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Axsome Therapeutics, Inc. | $163.72 | 4 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $163.23 | 2 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $60.64 | 3 | $0 (2024) |
| Lundbeck LLC | $28.43 | 1 | $0 (2024) |
| Alkermes, Inc. | $27.24 | 1 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $20.82 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $464.08 | 12 | Axsome Therapeutics, Inc. ($163.72) |
All Payment Transactions
12 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $13.97 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/21/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/21/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $2.44 | General |
| Category: Psychology/Psychiatric | ||||||
| 09/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $120.99 | General |
| Category: Psychology/Psychiatric | ||||||
| 08/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: PSYCHIATRY | ||||||
| 07/25/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $149.26 | General |
| Category: Psychiatry/Psychology | ||||||
| 05/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: CNS | ||||||
| 03/29/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $28.43 | General |
| Category: PSYCHIATRY | ||||||
| 03/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: Psychology/Psychiatric | ||||||
About Kate Shantar
Kate Shantar is a Psychiatric/Mental Health healthcare provider based in San Marino, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2023. The National Provider Identifier (NPI) number assigned to this provider is 1407635113.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kate Shantar has received a total of $464.08 in payments from pharmaceutical and medical device companies, with $464.08 received in 2024. These payments were reported across 12 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($464.08).
Practice Information
- Specialty Psychiatric/Mental Health
- Location San Marino, CA
- Active Since 09/22/2023
- Last Updated 09/22/2023
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1407635113
Products in Payments
- Auvelity (Drug) $163.72
- COBENFY (Drug) $163.23
- TRINTELLIX (Drug) $60.64
- REXULTI (Drug) $49.25
- ARISTADA (Drug) $27.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.